American Conference Institute: 10th Annual Summit on Biosimilars

American Conference Institute: 10th Annual Summit on Biosimilars

New York Marriott East Side Hotel
Speaking Engagement

The ACI Summit on Biosimilars is the industry’s one and only event directed to the legal, regulatory and commercial aspects of the biosimilars marketplace. The speaking faculty will consist of top innovator and biosimilar makers, government representatives and leading law firms as they discuss the hottest industry challenges and provide their skilled insights into the design and execution of successful biosimilars strategies.

WilmerHale Partner Kevin Prussia will speak on the “The ITC: Examining the Role of this Alternate Forum in Biosimilars Disputes” panel. Panelists will expand on:

  • Exploring the ITC as a venue for reaching a relatively swifter and earlier resolution of a biosimilars challenge
    • Weighing the pros and cons of avoiding the patent dance and assessing the benefits of asserting any number of claims in lieu of the aBLA process
  • Capitalizing on the benefit of receiving remedies beyond the restrictions imposed by the district courts

Read More About the Event



Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.